Matthew Shawn Morris Sells 59,037 Shares of Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. (NASDAQ:PRVA) Director Matthew Shawn Morris sold 59,037 shares of Privia Health Group stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $27.33, for a total transaction of $1,613,481.21. Following the transaction, the director owned 76,651 shares in the company, valued at approximately $2,094,871.83. This trade represents a 43.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shawn Morris also recently made the following trade(s):

• On Monday, July 6th, Matthew Shawn Morris sold 53,722 shares of Privia Health Group stock. The stock was sold at an average price of $27.24, for a total transaction of $1,463,387.28.
• On Monday, June 29th, Matthew Shawn Morris sold 63,212 shares of Privia Health Group stock. The stock was sold at an average price of $25.33, for a total value of $1,601,159.96.
• On Friday, June 26th, Matthew Shawn Morris sold 88,110 shares of Privia Health Group stock. The stock was sold at an average price of $25.33, for a total value of $2,231,826.30.
• On Friday, May 1st, Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock. The shares were sold at an average price of $24.99, for a total value of $427,229.04.
• On Monday, May 4th, Matthew Shawn Morris sold 1,017 shares of Privia Health Group stock. The shares were sold at an average price of $24.96, for a total value of $25,384.32.

Privia Health Group Stock Performance

Shares of PRVA traded up $0.04 during mid-day trading on Tuesday, reaching $27.23. 1,077,240 shares of the company were exchanged, compared to its average volume of 934,312. The business has a 50 day simple moving average of $23.53 and a two-hundred day simple moving average of $23.04. The stock has a market capitalization of $3.43 billion, a PE ratio of 170.20, a PEG ratio of 2.16 and a beta of 0.83. Privia Health Group, Inc. has a 52 week low of $18.77 and a 52 week high of $27.70.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the stock. Canaccord Genuity Group dropped their price target on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Evercore set a $26.00 target price on shares of Privia Health Group in a research note on Wednesday, April 8th. Barclays dropped their target price on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Finally, Weiss Ratings raised shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $31.15.

Hedge Funds Weigh In On Privia Health Group

A number of institutional investors and hedge funds have recently modified their holdings of PRVA. Royal Bank of Canada increased its stake in shares of Privia Health Group by 63.5% in the 1st quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock valued at $5,514,000 after acquiring an additional 95,371 shares in the last quarter. AQR Capital Management LLC grew its holdings in Privia Health Group by 24.7% in the first quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock worth $916,000 after purchasing an additional 8,068 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Privia Health Group by 3.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company’s stock valued at $2,666,000 after purchasing an additional 3,714 shares during the period. Intech Investment Management LLC raised its holdings in shares of Privia Health Group by 55.1% during the first quarter. Intech Investment Management LLC now owns 56,553 shares of the company’s stock valued at $1,270,000 after purchasing an additional 20,082 shares during the period. Finally, Acadian Asset Management LLC bought a new position in shares of Privia Health Group during the 1st quarter worth about $154,000. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.